Latest News

STAT Plus: Pharmalittle: Groups backed by pharma oppose equitable Covid-19 pricing; AstraZeneca strikes big Covid-19 vaccine deal



And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is exceedingly modest, since we must keep one eye on the firehose of news. Otherwise, we hope to catch up on our naps and stroll with the official mascot. And what about you? This may be a good time to engage in spring cleaning or you could reach out to someone feeling isolated. You might also want to help the economy by purchasing some new masks. Or simply take stock of the world. Well, whatever you do, have a sunny time. Be safe, and see you soon.

Novovax (NVAX) was awarded a contract by the Department of Defense for up to $60 million to support production of a Covid-19 vaccine that will be manufactured in the U.S. The news comes after the company failed to make the cut as one of the five vaccine finalists selected for the Operation Warp Speed project. The agreement includes a 2020 delivery of 10 million doses for DoD that could be used in Phase 2/3 clinical trials or under an Emergency Use Authorization if approved by the Food and Drug Administration.

Continue to STAT Plus to read the full story…

Source link

Related posts

Minomic与美国病理实验室签署协议

Newsemia

With latest defeat in South Dakota, drug pricing initiatives unlikely to see the ballot in 2018

Newsemia

Multimodal technologies in LEGO House: A social semiotic perspective

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World